1 | | 2 doses of Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2) | | Either— (a) both doses received before carrying out certain work; or (b) 1 dose received before carrying out certain work and the second dose received within 35 days of having the first dose |
2 | | 2 doses of AstraZeneca (Vaxzevria, AZD1222) | | Either— (a) both doses received before carrying out certain work; or (b) 1 dose received before carrying out certain work and the second dose received within 35 days of having the first dose |
3 | | 2 doses of AstraZeneca (Covishield) | | Both doses received before carrying out certain work |
4 | | 2 doses of Moderna (Spikevax, mRNA-1273) | | Both doses received before carrying out certain work |
5 | | 2 doses of Sinopharm, Beijing (BBIBP-CorV, Sinopharm COVID-19 vaccine, BIBP vaccine, Covilo) | | Both doses received before carrying out certain work |
6 | | 2 doses of Sinovac (CoronaVac, Sinovac COVID-19 vaccine, PiCoVacc) | | Both doses received before carrying out certain work |
7 | | 2 doses of Bharat Biotech (Covaxin, BBV152) | | Both doses received before carrying out certain work |
8 | | 1 dose of Janssen / Johnson & Johnson (Janssen COVID-19 Vaccine, Ad26.COV2.S, Ad26COVS1, JNJ-78436735) | | Dose received before carrying out certain work |
9 | | 2 doses of any combination of the following: Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2): Moderna (Spikevax, mRNA-1273): AstraZeneca (Vaxzevria, AZD1222): AstraZeneca (Covishield): Sinopharm, Beijing (BBIBP-CorV, Sinopharm COVID-19 vaccine, BIBP vaccine, Covilo): Sinovac (CoronaVac, Sinovac COVID-19 vaccine, PiCoVacc): Bharat Biotech (Covaxin, BBV152)
| | Both doses received before carrying out certain work |
10 | | 1 dose of any of the following: Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2): Moderna (Spikevax, mRNA-1273): AstraZeneca (Vaxzevria, AZD1222): AstraZeneca (Covishield): Sinopharm, Beijing (BBIBP-CorV, Sinopharm COVID-19 vaccine, BIBP vaccine, Covilo): Sinovac (CoronaVac, Sinovac COVID-19 vaccine, PiCoVacc): Bharat Biotech (Covaxin, BBV152)
| | 1 dose received before before carrying out certain work and 1 dose of Pfizer/BioNTech (Comirnaty, Tozinameran, BNT162b2) or AstraZeneca (Vaxzevria, AZD1222) within 35 days of having the first dose |
11 | | If a person has received 1 or 2 doses (or for Zydus Cadila, 1, 2 or 3 doses) of any of the following, then 1 additional dose of Pfizer/BioNTech, Moderna, AstraZeneca (Vaxzevria or Covishield) or Janssen vaccine is required to be treated as fully vaccinated: Sinopharm, Wuhan (Sinopharm/WIBP COVID-19 vaccine): Gamaleya Research Institute of Epidemiology and Microbiology (Sputnik V, Gam-COVID-Vac): Gamaleya Research Institute of Epidemiology and Microbiology (Sputnik light) (single-dose vaccine): Takeda (TAK-919, COVID-19 Vaccine Moderna Intramuscular Injection) (note: this is a Moderna formulation): CanSino (Convidecia, PakVac, Ad5-nCoV): Anhui Zhifei Longcom (Zifivax, ZF2001, ZF-UZ-VAC-2001): Beijing Minhai Biotechnology Co (KCONVAC, Minhai COVID-19 vaccine): Shifa Pharmed Industrial Co (COVIran Barekat, COVIRAN): Federal Budgetary Research Institution State Research Center of Virology and Biotechnology VECTOR FBRI (EpiVacCorona): Chumakov Centre (KoviVac): Khazakstan Research Institute for Biological Safety Problems, RIBSP (QazVac, QazCovid-in): Medigen Vaccine Biologics Corporation, MVC (MVC COVID-19 vaccine, Medigen COVID-19 vaccine, MVC-COV1901): Center for Genetic Engineering and Biotechnology, CIGB (Abdala, CIGB-66): Vaxine/CinnaGen Co COVAX-19. (SpikoGen): Serum Institute of India COVOVAX (Novavax formulation)
If the additional dose is administered in New Zealand, it should be given at least 28 days after the previous COVID-19 vaccine dose | | All doses must be received before carrying out certain work |